2Eastman P. Reimbursement policies discourage off - label drug use [ J ]. Oncology Times, 2005, 27 (20) :8 - 10.
3Kocs D, Fendrick AM. Effect of off - label use of oncology drugs on pharmaceutical costs: the ritux- imab experience [ J ]. Am J Manag Care, 2003,9 (5) :393 -400.
4Strode, A. E. , Slack, C. M., Wassenaar, D. R. ,et al. One step forward, two steps back -requiting min- isterial approval for all "non- therapeutic" health research involving minors [ J ]. S Mr Med J, 2007, 97 (3) :200 -202.